In a large study performed by the ICPCG consortium, 5% of Europeans with prostate cancer carried the HOXB13 variant, and it is particularly prevalent in Nordic countries where the frequency can be as high as 22% [94]. The gene discussed is HOXB13; the disease is Familial prostate cancer.